BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chau GY. Resection of hepatitis B virus-related hepatocellular carcinoma: Evolving strategies and emerging therapies to improve outcome. World J Gastroenterol 2014; 20(35): 12473-12484 [PMID: 25253947 DOI: 10.3748/wjg.v20.i35.12473]
URL: https://www.wjgnet.com/1948-5182/full/v20/i35/12473.htm
Number Citing Articles
1
Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Yun-Hsuan Lee, Yi-Hsiang Huang, Chien-Wei Su, Fa-Yauh Lee, Han-Chieh Lin, Teh-Ia Huo. Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patientsEuropean Journal of Cancer 2016; 63: 25 doi: 10.1016/j.ejca.2016.04.023
2
Hon-Fan Lai, Ivy Yenwen Chau, Hao-Jan Lei, Shu-Cheng Chou, Cheng-Yuan Hsia, Yi-Chu Kao, Gar-Yang Chau, Leonidas G Koniaris. Postoperative fever after liver resection: Incidence, risk factors, and characteristics associated with febrile infectious complicationPLOS ONE 2022; 17(1): e0262113 doi: 10.1371/journal.pone.0262113
3
Y J Chang, K P Chung, Y J Chang, L J Chen. Long-term survival of patients undergoing liver resection for very large hepatocellular carcinomasBritish Journal of Surgery 2016; 103(11): 1513 doi: 10.1002/bjs.10196
4
De-Fei Hong, Ying-Bin Liu, Shu-You Peng, Jin-Zhong Pang, Zhi-Fei Wang, Jian Cheng, Guo-Liang Shen, Yuan-Biao Zhang. Management of hepatocellular carcinoma rupture in the caudate lobeWorld Journal of Gastroenterology 2015; 21(26): 8163-8169 doi: 10.3748/wjg.v21.i26.8163
5
Yiqi Yu, Jingwen Ai, Wenhong Zhang. Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2017; 11(10): 925 doi: 10.1080/17474124.2017.1343665
6
Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Yun-Hsuan Lee, Chien-Wei Su, Yi-Hsiang Huang, Fa-Yauh Lee, Han-Chieh Lin, Teh-Ia Huo. Prognosis of hepatocellular carcinoma: Assessment of eleven staging systemsJournal of Hepatology 2016; 64(3): 601 doi: 10.1016/j.jhep.2015.10.029
7
Qiang Fang, Qing-Song Xie, Jiang-Ming Chen, Shen-Liang Shan, Kun Xie, Xiao-Ping Geng, Fu-Bao Liu. Long-term outcomes after hepatectomy of huge hepatocellular carcinoma: A single-center experience in ChinaHepatobiliary & Pancreatic Diseases International 2019; 18(6): 532 doi: 10.1016/j.hbpd.2019.09.001
8
Z. M. Younossi, M. Stepanova, S. Saab, A. Ahmed, B. Lam, M. Srishord, C. Venkatesan, H. Wai, L. Henry. The impact of viral hepatitis‐related hepatocellular carcinoma to post‐transplant outcomesJournal of Viral Hepatitis 2016; 23(1): 53 doi: 10.1111/jvh.12449
9
Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Yun-Hsuan Lee, Yi-Hsiang Huang, Yi-You Chiou, Han-Chieh Lin, Teh-Ia Huo. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2 cm in a Propensity Score ModelAnnals of Surgery 2016; 263(3): 538 doi: 10.1097/SLA.0000000000001178
10
Po‐Hong Liu, Chia‐Yang Hsu, Cheng‐Yuan Hsia, Yun‐Hsuan Lee, Yi‐You Chiou, Yi‐Hsiang Huang, Fa‐Yauh Lee, Han‐Chieh Lin, Ming‐Chih Hou, Teh‐Ia Huo. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD EraJournal of Gastroenterology and Hepatology 2017; 32(4): 879 doi: 10.1111/jgh.13608
11
Yueming Zhang, Jing Lv, Pingguo Liu, Xingyang Zhao, Kang Chen, Qiaolin Li, Liming Nie, Chihua Fang. Contrast-Enhanced Multispectral Photoacoustic Imaging for Irregular Hepatectomy Navigation: A Pilot StudyACS Biomaterials Science & Engineering 2020; 6(10): 5874 doi: 10.1021/acsbiomaterials.0c00921
12
Po-Hong Liu, Chia-Yang Hsu, Yun-Hsuan Lee, Chien-Wei Su, Cheng-Yuan Hsia, Yi-Hsiang Huang, Yi-You Chiou, Han-Chieh Lin, Teh-Ia Huo. Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular CarcinomaMedicine 2015; 94(41): e1772 doi: 10.1097/MD.0000000000001772
13
Chiara Rocha, Joseph Di Norcia, Parissa Tabrizian, Chiara Di Renzo, Salvatore Amodeo, Yuki Bekki, M Zeeshan Akhtar, Marcelo E. Facciuto, Thomas D. Schiano, Sander Florman, Myron Schwartz. Improved Outcomes of Liver Resection for Hepatitis C-related Hepatocellular Carcinoma After the Introduction of Direct-Acting Antiviral TherapyHPB 2024;  doi: 10.1016/j.hpb.2024.04.014
14
Guanlin Zhou, Yijun Zeng, Yingmin Luo, Sheng Guo, Longyuan Bao, Qiong Zhang. Urine miR-93-5p is a promising biomarker for early detection of HBV-related hepatocellular carcinomaEuropean Journal of Surgical Oncology 2022; 48(1): 95 doi: 10.1016/j.ejso.2021.06.015
15
Sheng-Yu Wang, Ivy Yenwen Chau, Cheng-Yuan Hsia, Hao-Jan Lei, Shu-Cheng Chou, Yi-Chu Kao, Gar-Yang Chau. Resection of hepatocellular carcinoma in patients with portal hypertension: long-term results based on direct intraoperative measurement of portal venous pressureInternational Journal of Surgery: Global Health 2020; 3(6): e34 doi: 10.1097/GH9.0000000000000034
16
Yu-Wen Su, Po-Hong Liu, Chia-Yang Hsu, Yun-Hsuan Lee, Cheng-Yuan Hsia, Shu-Yein Ho, Ming-Chih Hou, Harn-Shen Chen, Teh-Ia Huo, Sheng-Nan Lu. Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspectivePLOS ONE 2017; 12(3): e0174333 doi: 10.1371/journal.pone.0174333